Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-08 08:39 am Unchanged |
2024-12-31 | 13G | Seer, Inc. SEER |
Schindel Yair Chaim | 4,923,196 8.350% |
0 (Unchanged) |
Filing History |
| 2024-11-04 07:39 am Purchase |
2024-09-30 | 13G | Akoya Biosciences, Inc. AKYA |
Schindel Yair Chaim | 4,878,459 9.860% |
1,801,264 (+58.54%) |
Filing History |
| 2024-11-04 07:19 am Sale |
2024-09-30 | 13G | Sera Prognostics, Inc. SERA |
Schindel Yair Chaim | 1,911,332 5.730% |
-1,067,179 (-35.83%) |
Filing History |
| 2024-02-12 08:27 am Unchanged |
2023-12-31 | 13G | Advaxis, Inc. ADXS |
Schindel Yair Chaim | 560,602 1.310% |
0 (Unchanged) |
Filing History |
| 2024-01-03 08:52 am Unchanged |
2023-12-31 | 13G | Seer, Inc. SEER |
Schindel Yair Chaim | 4,923,196 7.710% |
0 (Unchanged) |
Filing History |
| 2024-01-03 08:50 am Purchase |
2023-12-31 | 13G | Akoya Biosciences, Inc. AKYA |
Schindel Yair Chaim | 3,077,195 6.270% |
158,756 (+5.44%) |
Filing History |
| 2024-01-03 08:50 am Purchase |
2023-12-31 | 13G | Sera Prognostics, Inc. SERA |
Schindel Yair Chaim | 2,978,511 9.500% |
1,060,000 (+55.25%) |
Filing History |
| 2023-10-23 06:45 am Unchanged |
2023-10-18 | 13G | Advaxis, Inc. ADXS |
Schindel Yair Chaim | 560,602 5.210% |
0 (Unchanged) |
Filing History |
| 2023-06-13 07:18 am Purchase |
2023-06-12 | 13G | Akoya Biosciences, Inc. AKYA |
Schindel Yair Chaim | 2,918,439 6.030% |
2,918,439 (New Position) |
Filing History |
| 2023-05-18 11:23 am Purchase |
2023-05-17 | 13D | SOPHiA GENETICS SA SOPH |
Schindel Yair Chaim | 4,933,205 7.680% |
1,722,338 (+53.64%) |
Filing History |
| 2023-01-30 06:01 am Purchase |
2023-01-19 | 13G | Advaxis, Inc. ADXS |
Schindel Yair Chaim | 560,602 12.200% |
560,602 (New Position) |
Filing History |
| 2023-01-23 4:29 pm Sale |
2023-01-19 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Schindel Yair Chaim | 0 0.000% |
-2,991,473 (Position Closed) |
Filing History |
| 2023-01-10 5:21 pm Unchanged |
2022-06-08 | 13D | Viracta Therapeutics, Inc. VIRX |
Schindel Yair Chaim | 7,392,237 19.350% |
0 (Unchanged) |
Filing History |
| 2023-01-10 4:35 pm Unchanged |
2022-06-08 | 13D | Viracta Therapeutics, Inc. VIRX |
Schindel Yair Chaim | 7,392,237 19.350% |
0 (Unchanged) |
Filing History |
| 2023-01-10 4:30 pm Purchase |
2023-01-09 | 13D | SOPHiA GENETICS SA SOPH |
Schindel Yair Chaim | 3,210,867 5.000% |
3,210,867 (New Position) |
Filing History |
| 2023-01-09 06:51 am Unchanged |
2022-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Schindel Yair Chaim | 2,991,473 20.180% |
0 (Unchanged) |
Filing History |
| 2023-01-09 06:47 am Unchanged |
2022-12-31 | 13G | Sera Prognostics, Inc. SERA |
Schindel Yair Chaim | 1,918,511 6.190% |
0 (Unchanged) |
Filing History |
| 2023-01-09 06:43 am Unchanged |
2022-12-31 | 13G | Seer, Inc. SEER |
Schindel Yair Chaim | 4,923,196 7.860% |
0 (Unchanged) |
Filing History |
| 2022-01-24 06:12 am Purchase |
2021-12-31 | 13G | Sera Prognostics, Inc. SERA |
Schindel Yair Chaim | 1,918,511 6.200% |
1,918,511 (New Position) |
Filing History |
| 2022-01-24 06:10 am Unchanged |
2021-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Schindel Yair Chaim | 2,991,473 21.470% |
0 (Unchanged) |
Filing History |